Navigation Links
Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting
Date:4/30/2009

ing statements include, without limitation, statements regarding the mechanism of action of AFP-464, its potential advantages, its potential for use in treating cancer, as well as the timing, progress and anticipated results of the clinical development and regulatory processes concerning AFP-464. These statements are based on our current beliefs and expectations as to such future outcomes, and are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. Factors that might cause such a material difference include, among others, risks that the results of clinical trials will not support our claims or beliefs concerning the effectiveness of AFP-464, our ability to finance our development of AFP-464, regulatory risks, and our reliance on third party researchers and other collaborators. We assume no obligation to update these statements, except as required by law.


'/>"/>
SOURCE Tigris Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. FDA Accepts Investigational New Drug (IND) Application for Tigris Pharmaceuticals GGTI-2418
2. Tigris Pharmaceuticals Files IND Application for GGTI-2418
3. Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009
4. OncoGenex Pharmaceuticals to Release First Quarter Financial Results
5. Vanda Pharmaceuticals Reports First Quarter 2009 Results
6. Onyx Pharmaceuticals Announces First Quarter 2009 Financial Results Teleconference and Webcast
7. Transcept Pharmaceuticals to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
8. Inimex Pharmaceuticals begins First Clinical Study of an Innate Defense Regulator
9. Cadence Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences
10. Santaris Pharma Delivers Six LNA-Based RNA Inhibitors to Enzon Pharmaceuticals Ahead of Schedule
11. Peregrine Pharmaceuticals Reports Positive Data in Second Phase II Bavituximab Breast Cancer Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...NEW YORK, Nov. 9 "Micro cap and sm...to receive more broker sponsorship and exposure as...the upturn in commodity-driven stocks like gold, s...ident of The Haft Group, Inc, Manhattan based inve...and small cap equities market in the US and Canada...
(Date:11/9/2009)... SCHIEDLBERG, Austria, November 9 /PRNewswire/ ... world have been working on the development of a,B...mmunication channel,between the brain and a comput...ients to communicate or to control devices in thei...last years some patients have been supervised by,t...
(Date:11/9/2009)...VIENNA, Va., Nov. 9 CEL-... that Dr. Kenneth S. Rosenthal, Professor of Immun...sities College of Medicine and Pharmacy, reported ... at the Cleveland Clinic and CEL-SCI on CEL-SCI,s ...at the 7th GTCbio Vaccine: "All Things Considered"...
(Date:11/9/2009)... LONDON, November 9 Following t...e US Food and Drug Administration (FDA), privately...tp://www.davalinternational.com ) has been informe...PRO(R) has been awarded an Orphan-Drug,designation...s (ALS). , ALS, also known as Lou Gehrig,...
Breaking Biology Technology:Haft Group says Bullish Commodity Market Triggers Small and Micro-cap Upsurge 2intendiX - Communication by Thoughts: First Patient-Ready System on the Market 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 3
....S. Patent and Trade Office issued U.S. Patent No....lymerase and Uses Thereof to the Wisconsin Alumni...y of the University of Wisconsin-Madison. ConjuGo...lectual property invented by its co-founder Richar...research group, which included ConjuGon scientist ...
...le System was chosen by Popular Science magazine ..., ,To be among the 100 selected by Popular Science...chnology must represent a significant step forward...ble System features In-Cell Charge Control (I-C3)t... the battery, instead of the charger. This breakt...
...built the supply chain industries first fully func...adio frequency identification (RFID) laboratory d...vironment. The RFID Lab is enabling RedPrairie cus...t and readability as they prepare for RFID complia...scenarios, the RFID Lab is helping companies deter...
Other Biology Technology:RedPrairie Builds RFID Lab - Enables Real-World Testing 2
(Date:11/9/2009)... LAS VEGAS, Nov. 9 CBS Vision, the...gency OMD, an Omnicom Media Group company, today a...w OMD,s clients access to the CBS Television City ... Las Vegas. ,, The new venture, which marries ...nty,s leading agencies, will be called Communicati...
(Date:11/9/2009)..., N.Y. Oncologists have had their hands tied beca...ions that disable a protein called p53. As a criti...cancer-fighting operations within cells. When cell...not be treated. , These tumors might be tough, ...rom Cold Spring Harbor Laboratory (CSHL). The chin...
(Date:11/9/2009)...f butterfly wings has inspired a 3.2m, three-year ...on in the fields of security, energy and the envir... technology company QinetiQ have just signed a col...sed on groundbreaking physical sciences research. ...s from the University of Exeter and QinetiQ will w...
Breaking Biology News(10 mins):CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 2CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 3CBS and OMD Partner to Provide the Agency With Access to the Network's Television City Research Facility in Las Vegas 4CSHL study shows that some malignant tumors can be shut down after all 2CSHL study shows that some malignant tumors can be shut down after all 3£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2Finances Trigger American Reluctance to Spend More on Healthier Foods 49018 1Finances Trigger American Reluctance to Spend More on Healthier Foods 49018 2Despite Generic Erosion of Key Brands the Hospital Acquired Gram Negative Infections Drug Market Will Increase by 241 Billion from 2008 to 2018 49015 1Despite Generic Erosion of Key Brands the Hospital Acquired Gram Negative Infections Drug Market Will Increase by 241 Billion from 2008 to 2018 49015 2Despite Generic Erosion of Key Brands the Hospital Acquired Gram Negative Infections Drug Market Will Increase by 241 Billion from 2008 to 2018 49015 3AirClic Mobile Business Solutions Clic for Bio Reference Laboratories Inc 49012 1AirClic Mobile Business Solutions Clic for Bio Reference Laboratories Inc 49012 2
...e that provides resistance to a fungal disease res...eld has been discovered by scientists from the US ...g more durable resistance to a devastating disease...he report, recently appointed to the John Innes Ce...previously been achieved using genes that are spec...
..., Virginia (Feb. 20, 2009) In a startling result,...Conservation Biology found that more than 80 perc...-2000 occurred in regions identified as the most b.... , Titled "Warfare in Biodiversity Hotspots," th...ntists compared major conflict zones with the Eart...
...rs at Uppsala University can now show that what is... sex. In fact, evolutionary conflicts between the...t are downright injurious to the opposite sex. Th...ournal Current Biology . , In both males and fem...ommon that one might like to think for one sex to...
Other Biology News:Gene to reduce wheat yield losses 2Study finds most wars occur in Earth's richest biological regions 2Study finds most wars occur in Earth's richest biological regions 3Mating that causes injuries 2
Bovine IgG2 ELISA Kit from Bethyl Laboratories
Dog IgE ELISA Kit from Bethyl Laboratories
PCP ELISA Kit, Single from Bio-Quant Inc.
...Protocol Development ,Antibody Titer and Optimal C...or Human Cells and Tissues ,Double Antibody Labeli...phatase, Immunogold, and Fluorescent detection ,Li...Localization in Transgenic Animals ,Hundreds of Sp...
Biology Products: